• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆 Klotho 和 FGF23 水平作为 2 型糖尿病患者 CKD 相关心脏疾病的生物标志物。

Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.

机构信息

Nephrology Department, Centro Hospitalar Universitário do Algarve, 800-836 Faro, Portugal.

Departamento de Ciências Biomédicas e Medicina, Universidade do Algarve, 8005-139 Faro, Portugal.

出版信息

Int J Mol Sci. 2019 Mar 27;20(7):1536. doi: 10.3390/ijms20071536.

DOI:10.3390/ijms20071536
PMID:30934737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6480092/
Abstract

BACKGROUND

Research over the past decade has focused on the role of Klotho as a cardio protective agent that prevents the effects of aging on the heart and reduces the burden of cardiovascular disease CVD. The role of the interaction between fibroblast growth factor 23-(FGF-23)/Klotho in Klotho-mediated actions is still under debate. The main objective was to ascertain the potential use of plasmatic Klotho and FGF23 as markers for CKD-associated cardiac disease and mortality.

METHODS

This was a prospective analysis conducted in an outpatient diabetic nephropathy clinic, enrolling 107 diabetic patients with stage 2⁻3 CKD. Patients were divided into three groups according to their left ventricular mass index and relative wall thickness.

RESULTS

Multinomial regression analysis demonstrated that low Klotho and higher FGF-23 levels were linked to a greater risk of concentric hypertrophy. In the generalized linear model (GLM), Klotho, FGF-23 and cardiac geometry groups were statistically significant as independent variables of cardiovascular hospitalization ( = 0.007). According to the Cox regression model, fatal cardiovascular events were associated with the following cardiac geometric classifications; eccentric hypertrophy ( = 0.050); concentric hypertrophy ( = 0.041), and serum phosphate ≥ 3.6 mg/dL ( = 0.025), FGF-23 ≥ 168 ( = 0.0149), α-klotho < 313 ( = 0.044).

CONCLUSIONS

In our population, Klotho and FGF23 are associated with cardiovascular risk in the early stages of CKD.

摘要

背景

过去十年的研究重点是 Klotho 作为一种心脏保护剂的作用,它可以防止衰老对心脏的影响,降低心血管疾病(CVD)的负担。成纤维细胞生长因子 23(FGF-23)/Klotho 之间相互作用在 Klotho 介导的作用中的作用仍存在争议。主要目的是确定血浆 Klotho 和 FGF23 作为 CKD 相关心脏疾病和死亡率的标志物的潜在用途。

方法

这是一项在门诊糖尿病肾病诊所进行的前瞻性分析,共纳入 107 例 2⁻3 期 CKD 的糖尿病患者。根据左心室质量指数和相对壁厚度将患者分为三组。

结果

多项回归分析表明,Klotho 水平低和 FGF-23 水平高与向心性肥厚的风险增加相关。在广义线性模型(GLM)中,Klotho、FGF-23 和心脏几何组作为心血管住院的独立变量具有统计学意义( = 0.007)。根据 Cox 回归模型,致命心血管事件与以下心脏几何分类相关;离心性肥厚( = 0.050);向心性肥厚( = 0.041)和血清磷酸盐≥3.6mg/dL( = 0.025),FGF-23≥168( = 0.0149),α-Klotho<313( = 0.044)。

结论

在我们的人群中,Klotho 和 FGF23 与 CKD 早期的心血管风险相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08dc/6480092/6523fda3ea7f/ijms-20-01536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08dc/6480092/6523fda3ea7f/ijms-20-01536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08dc/6480092/6523fda3ea7f/ijms-20-01536-g001.jpg

相似文献

1
Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.血浆 Klotho 和 FGF23 水平作为 2 型糖尿病患者 CKD 相关心脏疾病的生物标志物。
Int J Mol Sci. 2019 Mar 27;20(7):1536. doi: 10.3390/ijms20071536.
2
[Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].[形态发生蛋白FGF-23和Klotho以及糖蛋白硬化蛋白在评估心血管疾病风险和慢性肾脏病预后中的作用]
Ter Arkh. 2015;87(6):10-16. doi: 10.17116/terarkh201587610-16.
3
The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.成纤维细胞生长因子 23-klotho 轴与儿科慢性肾脏病患儿的组织多普勒超声心动图:一项前瞻性队列研究。
Pediatr Nephrol. 2018 Jan;33(1):147-157. doi: 10.1007/s00467-017-3766-5. Epub 2017 Aug 9.
4
Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.Klotho 与慢性肾脏病临床结局的关系:来自慢性肾脏病预后队列研究(CRIC)的结果
Am J Kidney Dis. 2024 Sep;84(3):349-360.e1. doi: 10.1053/j.ajkd.2024.02.008. Epub 2024 Apr 6.
5
[New markers of cardio-renal links in chronic kidney disease].[慢性肾脏病中心肾关联的新标志物]
Ter Arkh. 2013;85(6):17-24.
6
FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease.FGF23-klotho 轴作为伴有早期慢性肾病的 2 型糖尿病患者骨折的预测因素。
J Diabetes Complications. 2020 Jan;34(1):107476. doi: 10.1016/j.jdiacomp.2019.107476. Epub 2019 Oct 31.
7
Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.可溶性α-klotho独立于成纤维细胞生长因子23和磷酸盐预防尿毒症心肌病。
J Am Soc Nephrol. 2015 May;26(5):1150-60. doi: 10.1681/ASN.2014040325. Epub 2014 Dec 4.
8
[MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE].[慢性肾病患者血清中的形态发生蛋白——成纤维细胞生长因子和klotho]
Klin Med (Mosk). 2015;93(12):32-8.
9
[Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].[成纤维细胞生长因子23(FGF23)和α-klotho与慢性肾脏病患者心血管损伤的相关性]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Sep 28;42(9):1058-1065. doi: 10.11817/j.issn.1672-7347.2017.09.011.
10
Klotho levels: association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients.klotho水平:与2型糖尿病患者胰岛素抵抗及白蛋白与肌酐比值的关联
Int Urol Nephrol. 2017 Oct;49(10):1809-1814. doi: 10.1007/s11255-017-1646-3. Epub 2017 Jul 4.

引用本文的文献

1
Serum alpha-klotho levels associate with bone mineral density in chronic kidney disease patients from NHANES 2011 to 2016.2011年至2016年美国国家健康与营养检查调查(NHANES)中慢性肾病患者的血清α-klotho水平与骨矿物质密度相关。
Sci Rep. 2025 May 28;15(1):18760. doi: 10.1038/s41598-025-04024-1.
2
Klotho antiaging protein: molecular mechanisms and therapeutic potential in diseases.α-klotho抗衰老蛋白:疾病中的分子机制及治疗潜力
Mol Biomed. 2025 Mar 22;6(1):19. doi: 10.1186/s43556-025-00253-y.
3
Podocyte senescence: from molecular mechanisms to therapeutics.

本文引用的文献

1
Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II.成纤维细胞生长因子 23 与血管紧张素 II 的心血管相互作用。
Sci Rep. 2018 Aug 17;8(1):12398. doi: 10.1038/s41598-018-30098-1.
2
TGFβ-incurred epigenetic aberrations of miRNA and DNA methyltransferase suppress Klotho and potentiate renal fibrosis.TGFβ 诱导的 miRNA 和 DNA 甲基转移酶表观遗传异常抑制 Klotho 并促进肾纤维化。
Biochim Biophys Acta Mol Cell Res. 2017 Jul;1864(7):1207-1216. doi: 10.1016/j.bbamcr.2017.03.002. Epub 2017 Mar 7.
3
Potential application of klotho in human chronic kidney disease.
足细胞衰老:从分子机制到治疗策略。
Ren Fail. 2024 Dec;46(2):2398712. doi: 10.1080/0886022X.2024.2398712. Epub 2024 Sep 9.
4
Biomarkers of chronic kidney disease in older individuals: navigating complexity in diagnosis.老年个体慢性肾脏病的生物标志物:应对诊断中的复杂性
Front Med (Lausanne). 2024 Jul 11;11:1397160. doi: 10.3389/fmed.2024.1397160. eCollection 2024.
5
Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.Klotho 与慢性肾脏病临床结局的关系:来自慢性肾脏病预后队列研究(CRIC)的结果
Am J Kidney Dis. 2024 Sep;84(3):349-360.e1. doi: 10.1053/j.ajkd.2024.02.008. Epub 2024 Apr 6.
6
Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies.Klotho作为糖尿病肾病患者预后生物标志物的潜在应用:临床研究的荟萃分析
Ther Adv Chronic Dis. 2023 Dec 4;14:20406223231213246. doi: 10.1177/20406223231213246. eCollection 2023.
7
Fibroblast Growth Factor Signaling in Development and Disease.成纤维细胞生长因子信号在发育和疾病中的作用。
Int J Mol Sci. 2023 Jun 4;24(11):9734. doi: 10.3390/ijms24119734.
8
Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes.血清成纤维细胞生长因子 23 水平与 2 型糖尿病血管平滑肌功能障碍相关。
J Atheroscler Thromb. 2023 Dec 1;30(12):1838-1848. doi: 10.5551/jat.64000. Epub 2023 May 23.
9
Direct and indirect effects of fibroblast growth factor 23 on the heart.成纤维细胞生长因子 23 对心脏的直接和间接作用。
Front Endocrinol (Lausanne). 2023 Feb 24;14:1059179. doi: 10.3389/fendo.2023.1059179. eCollection 2023.
10
Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease.肾脏疾病中的klotho、氧化应激与线粒体损伤
Antioxidants (Basel). 2023 Jan 20;12(2):239. doi: 10.3390/antiox12020239.
klotho在人类慢性肾病中的潜在应用。
Bone. 2017 Jul;100:41-49. doi: 10.1016/j.bone.2017.01.017. Epub 2017 Jan 20.
4
Association between Soluble Klotho and Change in Kidney Function: The Health Aging and Body Composition Study.可溶性klotho与肾功能变化之间的关联:健康老龄化与身体成分研究
J Am Soc Nephrol. 2017 Jun;28(6):1859-1866. doi: 10.1681/ASN.2016080828. Epub 2017 Jan 19.
5
Erythropoiesis stimulating agents and reno-protection: a meta-analysis.促红细胞生成素与肾脏保护:一项荟萃分析
BMC Nephrol. 2017 Jan 11;18(1):14. doi: 10.1186/s12882-017-0438-4.
6
Soluble klotho binds monosialoganglioside to regulate membrane microdomains and growth factor signaling.可溶性klotho与单唾液酸神经节苷脂结合,以调节膜微区和生长因子信号传导。
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):752-757. doi: 10.1073/pnas.1620301114. Epub 2017 Jan 9.
7
Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort.常规超声心动图指标与心力衰竭和死亡事件的相关性:慢性肾功能不全队列研究。
Clin J Am Soc Nephrol. 2017 Jan 6;12(1):60-68. doi: 10.2215/CJN.02700316. Epub 2016 Nov 10.
8
Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.抑制瞬时受体电位阳离子通道6(TRPC6)可改善肾纤维化,并有助于可溶性α-klotho发挥肾脏保护作用。
Kidney Int. 2017 Apr;91(4):830-841. doi: 10.1016/j.kint.2016.09.039. Epub 2016 Dec 12.
9
Left Ventricular Geometry and Risk of Sudden Cardiac Arrest in Patients With Severely Reduced Ejection Fraction.射血分数严重降低患者的左心室几何形态与心脏性猝死风险
J Am Heart Assoc. 2016 Aug 18;5(8):e003715. doi: 10.1161/JAHA.116.003715.
10
Mortality in the United States, 2015.美国2015年的死亡率。
NCHS Data Brief. 2016 Dec(267):1-8.